LifeSpan Vision Ventures Invests in SENISCA
NORWALK, Conn., March 19, 2024 /PRNewswire/ — LifeSpan Vision Ventures, an investment firm specializing in longevity biotech investments, today announced
Read MoreNORWALK, Conn., March 19, 2024 /PRNewswire/ — LifeSpan Vision Ventures, an investment firm specializing in longevity biotech investments, today announced
Read MoreScientists at deCODE genetics, a subsidiary of Amgen, have published a study on actionable genotypes detected in the Icelandic population
Read MoreNORWALK, Conn., Oct. 30, 2023 /PRNewswire/ — LifeSpan Vision Ventures, an investment firm dedicated to longevity biotech, today announced an
Read MoreNORWALK, Conn., Oct. 23, 2023 /PRNewswire/ —Â LifeSpan Vision Ventures today announced an investment in Matter Bio, a longevity holding company
Read MoreNORWALK, Conn., Oct. 13, 2023 /PRNewswire/ — LifeSpan Vision Ventures, a venture capital firm dedicated to advancing the field of
Read MoreAim to propel electrification in hotter regions of the world with battery lifespan of about 9,000 cycles at 60℃ TOKYO,
Read MoreSpecial report on aging investigates the latest science, key biological drivers and companies driving the development of potential “Fountain of
Read More